KalVista Pharmaceuticals Investors

15 investors on Angel Roster list KalVista Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name KalVista Pharmaceuticals can appear together.

Investors listed
15
With verified email
53%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 KalVista Pharmaceuticals investors

The most complete profiles first. Showing 15 of 15.

  • Christoph WestphalVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more

    Verified email available

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Rich AldrichVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • David DonabedianVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Lea Hachigian

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many KalVista Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 15 KalVista Pharmaceuticals investors. 8 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (15), Private Equity Firms (6) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do KalVista Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (9).

Where are KalVista Pharmaceuticals investors based?

Most are based in the United States (14) and the United Kingdom (1).

Which companies have KalVista Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Pulmocide (15), Sitryx Therapeutics (15), Bicycle Therapeutics (15), ReShape Lifesciences (11) and Zarodex Therapeutics (11).

How do I contact KalVista Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.